Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 108.20
+0.20 (0.19%)
At close: Dec 5, 2025
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.80 billion as of December 5, 2025. Its market cap has decreased by -17.47% in one year.
Market Cap
1.80B
Enterprise Value
1.77B
Revenue
242.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
108.20
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.80B, an increase of 33.06%. That is a compound annual growth rate of 7.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 1.80B | -7.90% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 118.22B |
| Getinge AB | 57.39B |
| Sectra AB | 53.56B |
| Camurus AB | 36.00B |
| Medicover AB | 34.89B |
| Asker Healthcare Group AB | 34.84B |
| BioArctic AB | 28.29B |
| AddLife AB | 22.29B |